Prevalence of potentially neuropathic Campylobacter jejuni strains on commercial broiler chicken products

International Journal of Food Microbiology

Volumn 145, Issue 2-3, 2011, Pages 395-399

  Hardy, Christopher G ^a   Lackey, Leila G ^a,b   Cannon, Jessica ^b   Price, Lance B ^a,c   Silbergeld, Ellen K ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

Author keywords

Campylobacter jejuni; Enteritis; Food borne illness; Guillain Barr syndrome; Lipooligosaccharide; Miller Fisher syndrome; Neuropathy; Poultry; Virulence

Indexed keywords

LIPOOLIGOSACCHARIDE; SIALYLTRANSFERASE;

ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; BROILER; CAMPYLOBACTER ENTERITIS; CAMPYLOBACTER JEJUNI; CONTROLLED STUDY; DNA SEQUENCE; GENETIC POLYMORPHISM; GUILLAIN BARRE SYNDROME; NEUROPATHY; NONHUMAN; POLYMERASE CHAIN REACTION; POULTRY; PREVALENCE;

ANIMALS; BALTIMORE; CAMPYLOBACTER JEJUNI; CHICKENS; DNA, BACTERIAL; FOOD MICROBIOLOGY; GENES, BACTERIAL; POLYMORPHISM, GENETIC; POULTRY; PREVALENCE; SEQUENCE ANALYSIS, DNA;

BACTERIA (MICROORGANISMS); CAMPYLOBACTER JEJUNI;

EID: 79952187557     PISSN: 01681605     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijfoodmicro.2010.12.027     Document Type: Article

References (34)

1. Ang C.W., Jacobs B.C., et al. The Guillain-Barre syndrome: a true case of molecular mimicry. Trends in Immunology 2004, 25(2):61-66.
2. Buzby J., Roberts T., et al. Estimated annual costs of Campylobacter-associated Guillain Barre Syndrome 1997, United States Department of Agriculture.
3. de Zoete M.R., van Putten J.P., et al. Vaccination of chickens against Campylobacter. Vaccine 2007, 25(30):5548-5557.
4. Doorduyn Y., Van Pelt W., et al. Novel insight in the association between salmonellosis or campylobacteriosis and chronic illness, and the role of host genetics in susceptibility to these diseases. Epidemiology and Infection 2008, 136(9):1225-1234.
5. Engvall E.O., Brandstrom B., et al. Validation of a polymerase chain reaction/restriction enzyme analysis method for species identification of thermophilic campylobacters isolated from domestic and wild animals. Journal of Applied Microbiology 2002, 92(1):47-54.
6. Gilbert M., Karwaski M.F., et al. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. The Journal of Biological Chemistry 2002, 277(1):327-337.
7. Godschalk P.C., Heikema A.P., et al. The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome. The Journal of Clinical Investigation 2004, 114(11):1659-1665.
8. Habib I., Louwen R., et al. Correlation between genotype diversity, lipooligosacchradie gene locus class variation, and caco-2 cell invation potential of Campylobacter jejuni isolates from chicken meat and humans: contribution to virulotyping. Applied and Environmental Microbiology 2009, 75(13):4277-4288.
9. Hughes R.A., Rees J.H. Clinical and epidemiologic features of Guillain-Barre syndrome. The Journal of Infectious Diseases 1997, 176(Suppl 2):S92-S98.
10. Humphrey T., O'Brien S., et al. Campylobacters as zoonotic pathogens: a food production perspective. International Journal of Food Microbiology 2007, 117(3):237-257.
11. Hye J.B., Nachamkin I. Campylobacter jejuni cst-II polymorphisms and association with development of Guillain-Barre syndrome. Neurology 2007, 68(19):1633-1634.
12. Islam Z., van Belkum A., et al. Comparative genotyping of Campylobacter jejuni strains from patients with Guillain-Barre syndrome in Bangladesh. PLoS ONE 2009, 4(9):e7257.
13. Jacobs B.C., Rothbarth P.H., et al. The spectrum of antecedent infections in Guillain-Barre syndrome: a case-control study. Neurology 1998, 51(4):1110-1115.
14. Kapperud G., Espeland G., et al. Factors associated with increased and decreased risk of Campylobacter infection: a prospective case-control study in Norway. American Journal of Epidemiology 2003, 158(3):234-242.
15. Kimoto K., Koga M., et al. Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies. Neurology 2006, 67(10):1837-1843.
16. Koga M., Gilbert M., et al. Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrome after Campylobacter jejuni enteritis. The Journal of Infectious Diseases 2006, 193(4):547-555.
17. Koga M., Takahashi M., et al. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barre syndrome. Neurology 2005, 65(9):1376-1381.
18. McCarthy N., Giesecke J. Incidence of Guillaine-Barre Syndrome following infection with Campylobacter jejuni. American Journal of Epidemiology 2001, 153(6):610-614.
19. Moore J.E., Corcoran D., et al. Campylobacter. Veterinary Research 2005, 36(3):351-382.
20. Mullner P., Collins-Emerson J.M., et al. Molecular epidemiology of Campylobacter jejuni in a geographically isolated country with a uniquely structured poultry industry. Applied and Environmental Microbiology 2010, 76(7):2145-2154.
21. Parker C.T., Gilbert M., et al. Characterization of lipooligosaccharide-biosynthetic loci of Campylobacter jejuni reveals new lipooligosaccharide classes: evidence of mosaic organizations. Journal of Bacteriology 2008, 190(16):5681-5689.
22. Parker C.T., Horn S.T., et al. Comparison of Campylobacter jejuni lipooligosaccharide biosynthesis loci from a variety of sources. Journal of Clinical Microbiology 2005, 43(6):2771-2781.
23. Price L.B., Johnson E., et al. Fluoroquinolone-resistant Campylobacter isolates from conventional and antibiotic-free chicken products. Environmental Health Perspectives 2005, 113(5):557-560.
24. Price L.B., Lackey L.G., et al. The persistence of fluoroquinolone-resistant Campylobacter in poultry production. Environmental Health Perspectives 2007, 115(7):1035-1039.
25. Price L.B., Roess A., et al. Neurologic symptoms and neuropathologic antibodies in poultry workers exposed to Campylobacter jejuni. Journal of Occupational and Environmental Medicine 2007, 49(7):748-755.
26. Rosenquist H., Boysen L., et al. Danish strategies to control Campylobacter in broilers and broiler meat: facts and effects. Epidemiology and Infection 2009, 137(12):1742-1750.
27. Sahin O., Morishita T.Y., et al. Campylobacter colonization in poultry: sources of infection and modes of transmission. Animal Health Research Reviews 2002, 3(2):95-105.
28. Suzuki H., Yamamoto S. Campylobacter contamination in retail poultry meats and by-products in the world: a literature survey. The Journal of Veterinary Medical Science 2009, 71(3):255-261.
29. Tam C.C., Rodrigues L.C., et al. Guillain-Barre syndrome associated with Campylobacter jejuni infection in England, 2000-2001. Clinical Infectious Diseases 2003, 37(2):307-310.
30. Thakur S., Zhao S., et al. Antimicrobial resistance, virulence, and genotypic profile comparison of Campylobacter jejuni and Campylobacter coli isolated from humans and retail meats. Foodborne Pathogens and Disease 2010.
31. Weisent J., Seaver W., et al. Comparison of three time-series models for predicting campylobacteriosis risk. Epidemiology and Infection 2010, 138(6):898-906.
32. Wierzba T.F., Abdel-Messih I.A., et al. Campylobacter infection as a trigger for Guillain-Barre syndrome in Egypt. PLoS ONE 2008, 3(11):e3674.
33. Wong T.L., Hollis L., et al. Prevalence, numbers, and subtypes of Campylobacter jejuni and Campylobacter coli in uncooked retail meat samples. Journal of Food Protection 2007, 70(3):566-573.
34. Yuki N. Human gangliosides and bacterial lipo-oligosaccharides in the development of autoimmune neuropathies. Methods in Molecular Biology 2010, 600:51-65.